IRVINE, Calif.--(BUSINESS WIRE)--Jan. 17, 2006--South Korean Fraud Must Not Overshadow Breakthroughs, Promise of Both Adult and Embryonic Stem Cell Research, Says Francisco Silva. Amid the ongoing furor over fraudulent claims by South Korean researchers around creation of 11 independent embryonic stem cell lines, Francisco Silva, Executive Vice President of Research and Development for biotechnology firm PrimeGen Biotech LLC (www.primegenbiotech.com), is available to provide expert commentary about the development of stem cell lines -- and the effect the furor may have on the adult stem cell (ASC) and embryonic stem cell (ESC) research communities.
